825T allele of the G-protein β3 subunit gene (GNB3) is associated with impaired left ventricular diastolic filling in essential hypertension

Journal of Hypertension

Volumn 17, Issue 10, 1999, Pages 1457-1462

  Jacobi, Johannes ^a   Hilgers, Karl F ^a   Schlaich, Markus P ^a   Siffert, Winfried ^b   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

G protein; Hypertension; Left ventricular function; Polymorphism

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SUBUNIT;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE FILLING; HUMAN; MALE; PRIORITY JOURNAL; RNA SPLICING; SIGNAL TRANSDUCTION; WORLD HEALTH ORGANIZATION;

EID: 0032750937     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917100-00014     Document Type: Article

References (46)

1. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, et al. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol 1994, 53:120-126.
2. Devereux RB, Pickering TG, Cody RJ, Laragh JH. Relation of renin-angiotensin system to left ventricular hypertrophy and function in experimental and human hypertension. J Clin Hypertens 1987; 3:87-103.
3. Raman VK, Lee YA, Lindpaintner K. The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy. Am J Cardiol 1995; 76:18D-23D.
4. Schmieder RE, Langenfeld MRW, Friedrich A, Schobel HP, Gatzka CD, Weihprecht H. Angíotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996; 94:1304-1309.
5. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human essential hypertension: role of angiotensinogen. Cell 1992; 71:168-180.
6. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, et al. Angiotensingen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93:1285-1287.
7. Schmidt S, Sharma AM, Zilch O, Beige J, Walla-Friedel M, Ganten D, et al. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995; 10:1145-1148.
8. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330:1628-1633.
9. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Carribeans. J Clin Invest 1995; 98:687-692.
10. Rotimi C, Morrisson L, Cooper R, Oyejide C, Effiong E, Ladipo M, et al. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among the African Americans. Hypertension 1994; 24:591-594.
11. Atwood LD, Kammerer CM, Samollow PB, Hixson JE, Shade RE. Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension 1997; 30:326-331.
12. Jeunemaitre X, Liflon RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin-converting enzyme locus and human essential hypertension. Nature Genet 1992; 1:72-75.
13. Schmidt S, van Hooft IM, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin converting enzyme gene is apparently not related to high blood pressure: Dutch hypertension and offspring study. J Hypertens 1993; 11:345-348.
14. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, et al. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21:455-460.
15. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992; 184:9-15.
16. Bonnardeux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 1994; 24:63-69.
17. Wang WY, Zee RYL, Morris BJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet 1997; 51:31-34.
18. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Cinelli A, Salvetti M, et al. Angiotensin II type 1 receptor A/C1166 polymorphism: relationships with blood pressure and cardiovascular structure. Hypertension 1996; 28:1076-1080.
19. Hilgers KF, Langenfeld MRW, Schlaich M, Veelken R, Schmieder RE. 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to infused angiotensin II [Abstract]. J Hypertens 1998: 16 (suppl 2): S53.
20. Schmidt S, Beige J, Walta-Friedel M, Michel MC, Sharma AM, Ritz E. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 1997; 15:1385-1389.
21. 3 subunit variant with hypertension. Nature Genet 1998; 18:45-49.
22. Gatzka CD, Schmieder RE. Improved classification of dippers by individualized analysis of ambulatory blood pressure profiles. Am J Hypertens 1995; 8:666-671.
23. Lindpaintner K, Lee M, Larson MG, Rao S, Pfeffer MA, Ordivas JM et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996; 334:1023-1028.
24. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4:1222-1230.
25. De Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, et al. Assessment of left ventricular function in the midwall fractional shortening/end systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23:1444-1451.
26. Devereux RB, Savage DO, Sachs S, Laragh JH. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. Am J Cardiol 1983; 51:171-176.
27. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 56:450-458.
28. Schobel HP, Langenfeld M, Gatzka C, Scmieder RE. Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension. Am Heart J 1996; 132:1004-1009.
29. Norusis MJI. SPSS in SPSS for Windows, Professional Statistics, Release 6.0. Chicago: SPSS Inc, 1993.
30. Fouad FM, Slominski JM, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coli Cardiol 1984; 3:1500-1506.
31. Miller TR, Grossman SJ, Schectman KB, Biello DR, Ludbrook PA, Ehsani AA. Left ventricular diastolic filling and its association with age. Am J Cardiol 1986; 58:531-535.
32. Iskandrian AS, Hakki AH. Age-related changes in left ventricular diastolic performance. Am Heart J 1986; 112:75-78.
33. Oniki T, Hashimoto Y, Shumizu S, Kakuta T, Yajima M, Numano F. Effect of increasing heart rate on Doppler indices of left ventricular performance in healthy men. Br Heart J 1992; 68:425-429.
34. Mureddu GF, de Simone G, Greco R, Rosato GF, Contaldo F. Left ventricular filling in arterial hypertension. Influence of obesity and hemodynamic and Structural confounders. Hypertension 1997; 29:544-550.
35. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor far myocardial infarction. Nature 1992; 359:641-644.
36. Schunkert H, Hense HW, Holmer SR, Slender M, Perz S, Keil U et al. Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330:1634-1638.
37. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90:2622-2628.
38. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994; 267:H1107-H1111.
39. Clarkson PBM, Prasad N, MacLeod C, Burchell B, MacDonald M. Influence of the angiotensin converting enzyme I/D gene polymorphisms on left ventricular diastolic filling in patients with essential hypertension. J Hypertens 1997; 15:995-1000.
40. Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, et al. Influence of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996; 94:698-703.
41. Tiret L, Bonnardeux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994:344:910-913.
42. Feldman DR, Tan CM. G-protein alterations in hypertension and aging. Hypertension 1995; 26:725-728.
43. Yoshikawa H, Fukuda K, Wanaka Y, Kasamutsu K, Baba A, Nishio I, et al. Deficient activity of stimulatory nucleotide-binding regulatory protein in lymphocytes from patients with essential hypertension. Am J Hypertens 1994; 7:713-716.
44. Feldman DR, Chorazyczewski J, G-protein function is reduced in hypertension. Hypertension 1997; 29:422-427.
45. Gruska S, Ihrke R, Stolper S, Kraatz G, Siffert W. Prevalence of increased signal transduction in immortalized tymphoblasts from patients with essential hypertension and normotensíve subjects. Hypertension 1997; 15:29-33.
46. Siffert W. G proteins, hypertension, and coronary heart disease - novel findings and hypotheses. Kidney Blood Press Res 1996; 19:71-80.